The popularity of RAPTA-C in in vivo studies has steered the way for complexes of the type
[Ru (η 6-arene)(X)(Y)(Z)] n+ (where X, Y and Z are monodentate ligands) to be developed …

The small molecule anticancer agent cisplatin and its Pt (II) analogs carboplatin and
oxaliplatin are widely used to treat a variety of tumorigenic diseases. Despite their structural …

Recent clinical reports have highlighted the increasing occurrence of drug resistance of
known therapeutics. Particularly, antibiotic resistant microorganisms and multidrug …

Nowadays in cancer treatment, both metal complexes and organic molecules are being
widely used. Current years have seen a surge of interest in the application of organometallic …

Schiff bases are most the widely used class of molecules in organic as well as in inorganic
chemistry and are well known for fabricating stable metal complexes. Schiff bases and their …

Arene–ruthenium (II) complexes with carbothioamidopyrazoles at the C-2 and C-5 positions
have been recognized as chemotherapeutic agent alternatives to cisplatin and its oxaliplatin …

The pyrimidine scaffold represents one of the privileged structures in chemistry, and there
has been an increase in number of studies utilizing this scaffold and its derivatives. The …

A series of bis-salicylaldimine ligands bearing two ON-donor functions were reacted with
dichloro (p-cymene) ruthenium (II) dimer in the presence of base (NaOAc) and a series of …

Abstract Iron (II) and Ru (II) half-sandwich compounds encompass some promising pre-
clinical anticancer agents whose efficacy may be tuned by structural modification of the …

Half sandwich ruthenium, rhodium and iridium complexes containing pyridyl chalcone
analogues (L1 and L2) are prepared by the reaction of [(arene) M (µ-Cl) Cl] 2 (arene …